Next-generation sequencing of circulating tumor DNA to predict recurrence in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy. - Chen YH; Hancock BA; Solzak JP; Brinza D; Scafe C; Miller KD; Radovich M (NPJ breast cancer, 2017)